亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

安徽立創生物科技有限公司  

生物醫藥研發、生產、銷售,醫藥中間體的技術開發,技術轉讓,技術咨詢,化工原料及產品(除危險品和易制毒化學品)銷售,自營和代理各類商品及技術的進出口業務,(國家限定企業經營或禁止出口的商品除外)。(依法須經批準的項目,經相關部門批準后方可開展經營活動)

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:武冬杰
  • 電話:1332-9263899
  • 郵件:2012168181@qq.com
  • 傳真:0562-5822555
  • QQ:2012168181
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 1-溴-5氟戊烷生產廠家
1-溴-5氟戊烷生產廠家
單價 面議對比
詢價 暫無
發貨 安徽銅陵市付款后3天內
品牌 安徽立創
含量 99
過期 長期有效
更新 2020-03-13 14:41
 
詳細信息
名稱:1-溴-5-氟戊烷
別名:溴氟戊烷 1-溴-5氟戊烷
英文名稱:1-BROMO-5-FLUOROPENTANE;5-FLUOROPENTYL BROMIDE;1-bromo-5-fluoropentane
CAS:407-97-6
分子式:C5H10BrF
分子量:169.0353InChI:InChI=1/C5H10BrF/c6-4-2-1-3-5-7/h1-5H2
密度:1.303g/cm
沸點:162°C at 760 mmHg
閃點:50.1°C
作用:有機合成中間體 [1] 
相關類別: 醫藥中間體;鹵代物
©2025 安徽立創生物科技有限公司 版權所有   技術支持:化工網   訪問量:8163  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |